Part: 12         Session: 145678910111213141516171819202122         Page 388389390391392393394395396397398399400401402403404405406407408409410411412413414415416 of 999

And I haven't got any hard facts on it. But let's say it works a third of the time would be good, to some degree. It certainly is no panacea.

The radiologists have really never seemed to me to make a good summary of what effect could be expected under what circumstances At least I've never seen a good summary of it.

You mentioned the one task force in the area of immunology. What other task forces have come into being and what are they doing?

Well, there's a task force on the colon. There's a task force on breast cancer. But by task force it doesn't mean they're spending all this time on clinical problems. They're doing some clinical problems but they're also doing some so called basic research unrelated to clinical practice as part of the task force endeavor.

A task force or at least a group that I've triedto get established in the Cancer Institute, either under their grant division or their intramural contract efforts, which are separated as if they were their institutes, is for the cancer of the pancreas. Pancreas and lung are two of the most, considered two of the most hopeless sites for cancer there are, yet there's been no real effort trying to treat them with combination drugs, yet. There's the beginning of a lung cancer effort, but these things are just beginning, and they're pushed a little bit by the success of the treatment efforts in acute lymphatic leukemia and in Hodgkins' disease which were financed by the Cancer Institute.

Which you highlighted last fall.